Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational Biology. The Director brings a comprehensive background of academic, industry, and leadership experience to the Institute’s large-scale and dedicated research effort. Committed to unraveling the mysteries of the immune system, the Institute for Immunology is on a mission to advance the fundamental understanding of human immunology through the study of immune health and diseases. By leading the Bioinformatics and Computational Biology team in creating multiple data streams and through the integration of the data analysis pipeline for the overall Institute, this critical hire will be a key role in the Institute’s ability to improve diagnosis, treatment, and prevention of immune-related diseases at a scale of unparalleled precision. The Chase Group does not lose sight of the profound impact placements have on the future success of partnered organizations. The goal is to strive for the best possible result for both the candidate and the company, connecting life-changing organizations and executives. For more information about this role or how The Chase Group can assist with your next hire, please contact ken@chasegroup.com.
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational Biology. The Director brings a comprehensive background of academic, industry, and leadership experience to the Institute’s large-scale and dedicated research effort. Committed to unraveling the mysteries of the immune system, the Institute for Immunology is on a mission to advance the fundamental understanding of human immunology through the study of immune health and diseases. By leading the Bioinformatics and Computational Biology team in creating multiple data streams and through the integration of the data analysis pipeline for the overall Institute, this critical hire will be a key role in the Institute’s ability to improve diagnosis, treatment, and prevention of immune-related diseases at a scale of unparalleled precision. The Chase Group does not lose sight of the profound impact placements have on the future success of partnered organizations. The goal is to strive for the best possible result for both the candidate and the company, connecting life-changing organizations and executives. For more information about this role or how The Chase Group can assist with your next hire, please contact ken@chasegroup.com.- Categories: Life Sciences, Research & Development
Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group
Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as…
Successful Placement at Avidity
The Chase Group is pleased to announce the successful completion of the Vice President, Medical Affairs search for Avidity Biosciences. Nathan Weedin brings 15+ years…
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on…
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,…
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…